Swiss biotech--an overview of the industry and the key stakeholders 2010
Related Experiment Video
Updated: Jun 5, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
Published on: May 21, 2008
1Swiss Biotech Association, Wengistrasse 7, CH-8004 Zürich. alexakis@swissbiotech.org
Abstract:
This article presents the stakeholders of the Swiss Biotechnology sector. From academia to industry, from TechTransfer initiatives to state impulse programs, the sector has developed rapidly in the last years. Public Private Partnerships such as Life Science Clusters and collaborations between industry associations have proven to be an essential part for sustainable success for our national GDP. The author has extensive experience in the various sub-sectors.
Related Concept Videos
Production of Pharmaceuticals
Upstream Processing
Drug Products: Biologics, Biosimilars and Interchangeables
Preclinical Development: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
